Advanced Enzyme Technologies Ltd

BSE: 540025

30

total announcements

540025.BO · 15 min delayed

BSECorp ActionBuyback2 Sept 2026

Advanced Enzyme Technologies Ltd

Pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 02, 2026

Advanced Enzyme Technologies Ltd has submitted a daily report on the buyback of its equity shares under Regulation 18(i) of the SEBI (Buy-Back of Securities) Regulations, 2018, as amended. The company bought back 58,083 equity shares on September 02, 2026, at an average price of ₹295.3153.

Read more →📎 1 attachment
BSECorp ActionBuyback24 Aug 2026

Advanced Enzyme Technologies Ltd

Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026.

Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the equity shares bought back on August 24, 2026. The company has bought 40,876 equity shares through Emkay Global Financial Services Limited at an average price of ₹302.7754.

Read more →📎 1 attachment
BSECompany UpdateResults18 Aug 2026

Advanced Enzyme Technologies Ltd

Transcript of Conference Call held on August 12, 2026 for the Unaudited Financial Results for the Quarter ended June 30, 2026

Advanced Enzyme Technologies Ltd has released its unaudited financial results for Q1 FY27, showing a 2% YoY growth in revenue to INR 1,898 million, but a 7% sequential decline. The company's performance is affected by the global economic challenges and volatility in energy and raw material prices.

Read more →📎 1 attachment
BSECompany UpdateBuyback11 Aug 2026

Advanced Enzyme Technologies Ltd

Bord Resolution for the Buyback

Advanced Enzyme Technologies Ltd has announced a board resolution for a buyback of up to 10% of its paid-up equity share capital and free reserves through the open market route. The buyback will be at a price not exceeding ₹ 500 per equity share, and the maximum buyback size is ₹ 697,000,000. The company will utilize at least 75% of the buyback size towards the buyback, and at least 40% of the buyback size will be utilized within the initial half of the offer period.

Read more →📎 1 attachment
BSECompany UpdateBuyback11 Aug 2026

Advanced Enzyme Technologies Ltd

Public Announcement - BuyBack of the Equity Shares

Advanced Enzyme Technologies Ltd has announced a buyback of its equity shares from the open market through stock exchanges under the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended. The buyback will open on August 14, 2026, and will end on the earlier of sixty-six working days, completion of the buyback, or a date determined by the Board.

Read more →📎 1 attachment
BSECompany UpdateResults10 Aug 2026

Advanced Enzyme Technologies Ltd

Please find enclosed herewith the copy of newspaper publication of extract of unaudited consolidated financial results for the quarter ended June 30, 2026.

Advanced Enzyme Technologies Ltd has published its unaudited consolidated financial results for the quarter ended June 30, 2026, in accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
BSECompany UpdateResults8 Aug 2026

Advanced Enzyme Technologies Ltd

Press Release titled Quaterly Earnings Release dated August 08, 2026

Advanced Enzyme Technologies Limited announced its unaudited financial results for the first quarter ended June 2026, with revenue increasing by 2% year-on-year to ₹1,898 million and EBITDA margin standing at 27%. Profit after tax de-grew by 5% to ₹386 million.

Read more →📎 1 attachment
Page 1 of 2Next →